Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 4838-4842, December 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Purnell, D. M.
Right arrow Articles by Kontra, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Purnell, D. M.
Right arrow Articles by Kontra, J.

Comparative Antitumor Effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and Levamisole Alone or in Combination with Cyclophosphamide in the CaD2 Murine Mammary Adenocarcinoma System1

Dallas M. Purnell2, Gerald L. Bartlett3, John W. Kreider, Timothy G. Biro and Joseph Kontra

Department of Pathology [D. M. P.], School of Medicine, University of Maryland, Baltimore, Maryland 21201, and the Departments of Pathology [G. L. B., J. W. K., T. G. B., J. K.] and Microbiology [G. L. B., J. W. K.] and Specialized Cancer Research Center [G. L. B., J. W. K.], The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033

The antitumor efficacy of various immune stimulants [Corynebacterium parvum, Bordetella pertussis, and Bacillus Calmette-Guérin (BCG)] and levamisole alone or in conjunction with cyclophosphamide (CY) was studied in the CaD2 mammary adenocarcinoma system using schedules developed previously with C. parvum and CY.

Weekly systemic treatment with C. parvum, B. pertussis, or BCG was effective in controlling tumor growth and had equivalent antitumor effects, but weekly treatment (or a single treatment) with levamisole was ineffective. Weekly treatment with B. pertussis was better than treatment given only once, but repeated treatment with C. parvum or BCG was not more effective than a single treatment with these agents. When administered as a single systemic injection, C. parvum was superior to B. pertussis in controlling tumor growth, but a single systemic injection of BCG was as effective as C. parvum. Systemic administration of immune stimulants had variable effects on survival, which were sometimes not correlated with effects on tumor size.

Combined treatment with BCG and CY was significantly more effective than CY treatment alone in controlling tumor growth in most trials, as was combination treatment with C. parvum and CY. Combination treatment with B. pertussis and CY was not better in prolonging survival than CY alone. Levamisole rarely improved the antitumor effect of CY chemotherapy and had no effect on survival compared to the effect of CY alone.

1 Supported by Contract N01-CB-33891 and Grant P30-CA18450 from the National Cancer Institute and by funds from the Jake Gittlen Memorial Golf Tournament.

2 To whom requests for reprints should be addressed.

3 Recipient of USPHS Career Development Award K04-CA70948 from The National Cancer Institute.

Received 5/ 9/79. Accepted 9/ 5/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.